Regardless of the type of disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) those who receive the second COVID-19 vaccine booster dose. 2) patients who visit or are admitted to or undergoing a home visit from Hofu Rehabilitation Hospital. 3) Persons who have received sufficient explanation regarding participation in this study with voluntary written consent provided by the person or their guardians after sufficient understanding.
Exclusion criteria
Exclusion criteria: 1) Those who do not wish to be vaccinated with second COVID-19 vaccine booster dose. 2) Those who are judged to be inappropriate for registration at the discretion of the doctor in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of immune response between residents of long-term care facilities and outpatients at four weeks and 24 weeks after the second COVID-19 vaccine booster dose. | — |
Secondary
| Measure | Time frame |
|---|---|
| The assessment of associations vaccine immunogenicity at four weeks and 24 weeks after the second COVID-19 vaccine booster dose with the clinical background of participants. | — |
Countries
Japan
Contacts
Graduate School of Medicine, Yamaguchi University Department of Pulmonology and Gerontology